KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Astrazeneca (AZN) over the last 17 years, with Q4 2025 value amounting to $5.8 billion.

  • Astrazeneca's Long-Term Deferred Tax rose 882.74% to $5.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.8 billion, marking a year-over-year increase of 882.74%. This contributed to the annual value of $5.8 billion for FY2025, which is 882.74% up from last year.
  • According to the latest figures from Q4 2025, Astrazeneca's Long-Term Deferred Tax is $5.8 billion, which was up 882.74% from $6.1 billion recorded in Q3 2025.
  • Astrazeneca's 5-year Long-Term Deferred Tax high stood at $6.3 billion for Q2 2025, and its period low was $3.3 billion during Q4 2022.
  • Its 5-year average for Long-Term Deferred Tax is $4.5 billion, with a median of $4.3 billion in 2021.
  • Per our database at Business Quant, Astrazeneca's Long-Term Deferred Tax skyrocketed by 6476.86% in 2021 and then crashed by 2464.2% in 2022.
  • Astrazeneca's Long-Term Deferred Tax (Quarter) stood at $4.3 billion in 2021, then dropped by 24.64% to $3.3 billion in 2022, then skyrocketed by 44.59% to $4.7 billion in 2023, then increased by 13.33% to $5.3 billion in 2024, then grew by 8.83% to $5.8 billion in 2025.
  • Its Long-Term Deferred Tax was $5.8 billion in Q4 2025, compared to $6.1 billion in Q3 2025 and $6.3 billion in Q2 2025.